Interestingly, tumor growth inhibition and increased rates of CD8 cytotoxic tumor infiltrating lymphocyte (TIL) and vascular normalization have been achieved after therapeutic vaccination against DLK1 in RENCA-bearing mice (Chi Sabins et al., 2013). Here, DLK1 is linked to neoplasm.